RxFunction

RxFunction is a private, commercial-stage medical device company addressing a significant unmet need in the management of sensory peripheral neuropathy. Its core technology, Walkasins, is a wearable lower-limb sensory prosthesis that provides haptic feedback to the leg based on real-time foot pressure data, aiming to reduce fall risk and improve mobility. The company is positioned in the cardiovascular and medical device sectors, targeting a large and growing patient population with limited pharmacological treatment options. RxFunction appears to be in an early revenue-generating phase, commercializing its first FDA-cleared device through a prescription model.

Wearable lower-limb sensory prosthesis that uses a sensor insole and haptic feedback on the leg to replace lost foot pressure sensation for balance control.

Direct competition for a wearable sensory prosthesis is currently limited. However, Walkasins competes indirectly with the standard of care, which includes physical therapy, balance training programs, and traditional assistive devices (canes, walkers). It also competes for mindshare and healthcare dollars within the broader neuropathy management market, which includes pain-focused pharmaceuticals and devices.